Rheumatology
| Gout
Rheumatology
Gout

Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial

book_2 Source: Ann Rheum Dis. 2023;82(12):1626-1634.
calendar_today Published on Medfyle: December 2023
import_contacts 7 min
headphones 6 min

In this medfyle

Gout is very common, and although there are urate-lowering therapies available, many people experience flares when they first go on treatment. New strategies explore anti-inflammatory prophylaxis, and dose-escalation protocols.

This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.

Expert commentary

Johannes Bijlsma, MD, PhD

Emeritus Professor of Rheumatology, Utrecht University, The Netherlands.
Past associate editor ARD (2000-2018) and Past President of EULAR (2017-2019).

About this Medfyle
Read more arrow_downward Hide arrow_upward

©2023 Medfyle. All rights reserved.

Stamp L, Horne A, Mihov B, Drake J, Haslett J, Chapman PT, Frampton C, Dalbeth N. Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial. Ann Rheum Dis. 2023 Dec;82(12):1626-1634. doi: 10.1136/ard-2023-224731. Epub 2023 Aug 31. PMID: 37652661.

The authors of the original article and the publisher were not involved in the creation of the summary.


Feedback